Be Ready to Help Your Crohn's Disease Patients Start Biologics

July 2018

You'll see biologics considered earlier for Crohn's disease...partly due to new guidelines from the Am College of Gastroenterology.

This "top-down" approach is becoming more popular...versus waiting to see if meds such as sulfasalazine, mesalamine, or corticosteroids help.

For Crohn's, anticipate seeing infliximab (Remicade), adalimumab (Humira), certolizumab (Cimzia), vedolizumab (Entyvio), etc. These can lead to faster and longer-lasting remission for some higher-risk patients.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote